Agomelatine for the treatment of generalised anxiety disorder

Description

In this Product Explainer, Psychiatrist Prof Sean Hood explains the role of the antidepressant agomelatine in the treatment of Generalised Anxiety Disorder (GAD) (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Scientia Prof Kaarin Anstey

Scientia Prof Kaarin Anstey

New Brain Health Guidelines – What GPs Can Do

Expert panel – Dr Georgia Rigas & Dr Nadia Tejani, facilitated by Dr Angela Kwong

Expert panel – Dr Georgia Rigas & Dr Nadia Tejani, facilitated by Dr Angela Kwong

Navigating Perimenopause and Menopause – Managing Weight, Health and Wellbeing in General Practice

A/Prof Daryl Efron

A/Prof Daryl Efron

Autism & Mental Health Comorbidities

Dr Rebecca Purvis

Dr Rebecca Purvis

Pharmacogenomics in General Practice

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Sean Hood

expert

Prof Sean Hood

Psychiatrist; Head, University of Western Australia, Division of Psychiatry in the Medical School; Associate Dean, Faculty of Health and Medical Sciences

Date published: 8 August 2022